Valuation: SSY Group Limited

Market Cap 7.07B 901M 772M 720M 661M 1.24B 86.25B 1.27B 8.54B 3.33B 43.23B 3.38B 3.31B 143B P/E 2026 *
12.5x
P/E 2027 * 10.2x
Enterprise Value 7.07B 901M 772M 720M 661M 1.24B 86.25B 1.27B 8.54B 3.33B 43.23B 3.38B 3.31B 143B EV / Sales 2026 *
1.45x
EV / Sales 2027 * 1.29x
Free-Float
33.48%
Yield 2026 *
4.09%
Yield 2027 * 4.5%
1 day-0.41%
1 week+1.25%
Current month+2.31%
1 month-1.02%
3 months+2.74%
6 months-15.74%
Current year-13.96%
1 week 2.38
Extreme 2.385
2.55
1 month 2.36
Extreme 2.36
2.55
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.4
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.75
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 2010-03-22
Director of Finance/CFO 45 2015-03-31
Corporate Officer/Principal 42 2024-08-27
Director TitleAgeSince
Chairman 69 2014-06-03
Director/Board Member 61 2007-07-25
Director/Board Member 57 2005-10-15
Date Insider Type Main position Quantity % Market Cap.
1/9/26 Other

Chief Executive Officer

456,000 0.0155%
1/8/26 Other

Chief Executive Officer

1,486,000 0.0504%
1/7/26 Other

Chief Executive Officer

1,128,000 0.0382%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+1.25%-20.42%-40.75% 885M
-2.81%+2.93%+76.40%+127.73% 1,141B
-2.21%+2.02%+49.50%+55.01% 659B
-1.56%+4.39%+25.19%+74.39% 470B
+1.20%+2.62%+41.69%+45.78% 366B
-0.61%+2.10%+23.43%+41.34% 302B
+0.32%+3.25%+0.94%+13.42% 254B
-1.95%+3.80%+46.31%+65.66% 239B
-1.10%-0.70%-14.31%-52.66% 207B
-2.82%+3.84%+20.81%+89.04% 183B
Average -1.19%+2.38%+24.95%+41.89% 382.19B
Weighted average by Cap. -1.64%+3.12%+43.47%+70.83%

Financials

2026 *2027 *
Net sales 4.88B 622M 532M 497M 456M 857M 59.51B 873M 5.89B 2.3B 29.82B 2.34B 2.28B 98.73B 5.47B 698M 597M 557M 512M 961M 66.77B 980M 6.61B 2.58B 33.46B 2.62B 2.56B 111B
Net income 587M 74.86M 64.09M 59.8M 54.87M 103M 7.16B 105M 709M 277M 3.59B 281M 275M 11.88B 702M 89.45M 76.59M 71.46M 65.57M 123M 8.56B 126M 848M 330M 4.29B 336M 329M 14.2B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,472
Date Price Change Volume
26-08-20 HK$2.450 +0.20% 318,000
26-08-20 HK$2.445 +1.87% 10,526,000
26-08-19 HK$2.400 -0.62% 2,658,000
26-08-18 HK$2.415 +0.21% 2,090,000
26-08-17 HK$2.410 +0.21% 1,388,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.445HKD
Average target price
3.640HKD
Spread / Average Target
+48.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock